|
WO2017214514A1
|
|
Use of src family kinase inhibitor in ribosomal disorder
|
|
US2019008918A1
|
|
Immunomodulation therapies for cancer
|
|
WO2016179576A1
|
|
Novel immunomodulatory therapeutic strategies targeting tumors in cancer
|
|
US2018094058A1
|
|
Compositions and methods for preventing tumor growth and treating cancer by targeting lectin galactoside-binding soluble 3 binding protein
|
|
EP3224263A1
|
|
Use of ubiquitin-proteasome system inhibitors for treatment of tumors associated with neurofibromatosis type-2
|
|
WO2016061554A1
|
|
Synergistic composition of known, safe pharmaceuticals for use in insomnia and a method of treatment thereof
|
|
EP3206685A1
|
|
Prevention or treatment of sleep disorders using dexmedetomidine formulation
|
|
US2017220767A1
|
|
Methods for reformulating and repositioning pharmaceutical data and devices thereof
|
|
US2018226156A1
|
|
Methods for assessing pharmaceutical performance across therapeutic areas and devices thereof
|
|
US2016063202A1
|
|
Systems and methods to classify and rank health information
|
